Works matching IS 0741238X AND DT 2023 AND VI 40 AND IP 6
Results: 20
Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured Interviews.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2915, doi. 10.1007/s12325-023-02519-9
- By:
- Publication type:
- Article
Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2886, doi. 10.1007/s12325-023-02518-w
- By:
- Publication type:
- Article
Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2563, doi. 10.1007/s12325-023-02511-3
- By:
- Publication type:
- Article
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2752, doi. 10.1007/s12325-023-02510-4
- By:
- Publication type:
- Article
Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2855, doi. 10.1007/s12325-023-02508-y
- By:
- Publication type:
- Article
Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2626, doi. 10.1007/s12325-023-02507-z
- By:
- Publication type:
- Article
Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) for Preventing Recurrent Clostridioides difficile Infection in the US.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2801, doi. 10.1007/s12325-023-02506-0
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides difficile Infection in the USA.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2784, doi. 10.1007/s12325-023-02505-1
- By:
- Publication type:
- Article
Assessment of the Androgen Receptor in Older Women with Primary Breast Cancer: Association with a Panel of Biomarkers and Breast Cancer Specific Survival.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2820, doi. 10.1007/s12325-023-02504-2
- By:
- Publication type:
- Article
The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2741, doi. 10.1007/s12325-023-02503-3
- By:
- Publication type:
- Article
Advances in Clinical Cardiology 2022: A Summary of Key Clinical Trials.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2595, doi. 10.1007/s12325-023-02502-4
- By:
- Publication type:
- Article
Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2902, doi. 10.1007/s12325-023-02500-6
- By:
- Publication type:
- Article
Association Between Percutaneous Oxygen Saturation and Mortality of Patients with Mild Traumatic Brain Injury at ICU Admission: An Analysis of the MIMIC-III Database.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2773, doi. 10.1007/s12325-023-02499-w
- By:
- Publication type:
- Article
Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ).
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2573, doi. 10.1007/s12325-023-02489-y
- By:
- Publication type:
- Article
Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2836, doi. 10.1007/s12325-023-02484-3
- By:
- Publication type:
- Article
Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2869, doi. 10.1007/s12325-023-02482-5
- By:
- Publication type:
- Article
A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2577, doi. 10.1007/s12325-023-02479-0
- By:
- Publication type:
- Article
Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2693, doi. 10.1007/s12325-023-02476-3
- By:
- Publication type:
- Article
Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2725, doi. 10.1007/s12325-023-02462-9
- By:
- Publication type:
- Article
Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2710, doi. 10.1007/s12325-022-02384-y
- By:
- Publication type:
- Article